Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs